Haemonetics HAE Cash Flow Statement
| TTM Q4 '26 | TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | ||
|---|---|---|---|---|---|---|
| —— | $175.44M+4.3% | $168.19M+3.0% | $163.34M-2.6% | $167.68M+28.9% | ||
| $111.72M-0.8% | $112.61M-1.4% | $114.25M-0.8% | $115.21M-0.3% | $115.59M+0.5% | ||
| $33.83M+6.9% | $31.64M-1.3% | $32.05M+2.3% | $31.32M+5.7% | $29.64M-1.6% | ||
| $293.22M-13.5% | $338.84M+17.2% | $289.04M+27.6% | $226.54M+24.7% | $181.73M+40.6% | ||
| $32.78M+6.6% | $30.76M-6.7% | $32.96M-11.8% | $37.38M-4.8% | $39.28M+29.5% | ||
| $60.18M— | —— | —— | —— | —— | ||
| -$179.55M— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $0— | —— | —— | —— | —— | ||
| $0-100% | $6.25M0.0% | $6.25M+33.3% | $4.69M0.0% | $4.69M-29.2% | ||
| -$180.49M— | —— | —— | —— | —— | ||
| -$64.85M— | —— | —— | —— | —— | ||
| $260.44M-15.5% | $308.08M+20.3% | $256.08M+35.4% | $189.17M+32.8% | $142.45M+44.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Haemonetics's cash flow data come from?
- Every line is extracted from Haemonetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.